Marco Hofmann

Marco Hofmann

Company: Boehringer Ingelheim

Job title: Scientific Director & Group Leader

Seminars:

Live Panel Q&A – Ask Speakers Your Burning Questions 10:10 am

Read more

day: Day One

Staying One Step Ahead of KRAS 9:20 am

BI’s approaches to selectively drugging KRAS mutants, discussing mutant selective KRASG12Ci, KRASG12Di & combination opportunities BI’s approaches to discovering pan-KRAS medicines, addressing broad KRAS mutation driven patient populations with high medical need, including KRAS G12D, G12V, G13D in NSCLC, CRC and PDAC Rationale for positioning in KRAS wild-type cancer e.g. NF1-LoF and combination opportunities Future…Read more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.